Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 279

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Nuclear domain ‘knock-in’ screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing

Open access
Pinder, Jordan, Salsman, Jayme, Dellaire, Graham·2015·Nucleic Acids Research

Abstract

CRISPR is a genome-editing platform that makes use of the bacterially-derived endonuclease Cas9 to introduce DNA double-strand breaks at precise locations in the genome using complementary guide RNAs. We developed a nuclear domain knock-in screen, whereby the insertion of a gene encoding the green fluorescent protein variant Clover is inserted by Cas9-mediated homology directed repair (HDR) within the first exon of genes that are required for the structural integrity of subnuclear domains such as the nuclear lamina and promyelocytic leukemia nuclear bodies (PML NBs). Using this approach, we compared strategies for enhancing CRISPR-mediated HDR, focusing on known genes and small molecules that impact non-homologous end joining (NHEJ) and homologous recombination (HR). Ultimately, we identified the small molecule RS-1 as a potent enhancer of CRISPR-based genome editing, enhancing HDR 3- to 6-fold depending on the locus and transfection method. We also characterized U2OS human osteosarcoma cells expressing Clover-tagged PML and demonstrate that this strategy generates cell lines with PML NBs that are structurally and functionally similar to bodies in the parental cell line. Thus, the nuclear domain knock-in screen that we describe provides a simple means of rapidly evaluating methods and small molecules that have the potential to enhance Cas9-mediated HDR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkv993

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 49

  1. 10.1016/j.tibtech.2013.04.004 · DOI · Paper page
  2. 10.1038/nature08703 · DOI · Paper page
  3. 10.1099/mic.0.023960-0 · DOI · Paper page
  4. 10.1016/j.cell.2013.08.021 · DOI · Paper page
  5. 10.1101/gr.177220.114 · DOI · Paper page
  6. 10.1093/nar/gku806 · DOI · Paper page
  7. 10.1038/cr.2013.45 · DOI · Paper page
  8. 10.1093/nar/gkt135 · DOI · Paper page
  9. 10.1016/j.jgg.2013.12.004 · DOI · Paper page
  10. 10.1016/j.neuron.2014.04.036 · DOI
  11. 10.1016/j.cell.2012.09.042 · DOI · Paper page
  12. 10.1038/nrd3010 · DOI · Paper page
  13. 10.1038/nbt.3155 · DOI · Paper page
  14. 10.1101/gad.946401 · DOI · Paper page
  15. 10.1016/S0968-0004(98)01232-8 · DOI · Paper page
  16. 10.1242/jcs.031922 · DOI · Paper page
  17. 10.1186/1757-5036-3-3 · DOI
  18. Fagioli, 1992, Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms, Oncogene, 7, 1083
  19. 10.1158/0008-5472.CAN-05-3792 · DOI
  20. 10.1038/sj.onc.1204765 · DOI · Paper page
  21. 10.1242/jcs.00758 · DOI
  22. 10.1038/mtna.2014.64 · DOI · Paper page
  23. 10.1038/nmeth.2521 · DOI · Paper page
  24. 10.1016/S0092-8674(00)81847-4 · DOI · Paper page
  25. 10.1007/s00412-014-0484-7 · DOI
  26. 10.1073/pnas.0808046105 · DOI
  27. 10.1016/j.jbiotec.2007.11.002 · DOI
  28. 10.1016/j.molcel.2013.01.001 · DOI · Paper page
  29. Dever, 2011, Mutations in the BRCT binding site of BRCA1 result in hyper-recombination, Aging (Albany NY), 3, 515, 10.18632/aging.100325 · DOI
  30. 10.1016/j.cell.2012.11.054 · DOI · Paper page
  31. 10.1038/nbt.3198 · DOI · Paper page
  32. 10.1038/nrm2277 · DOI · Paper page
  33. 10.1016/j.yexcr.2013.09.001 · doi:10.1016/j.yexcr.2013.09.001
  34. 10.1038/onc.2012.576 · DOI
  35. Ben-Shoshan, 2014, Induction of polyploidy by nuclear fusion mechanism upon decreased expression of the nuclear envelope protein LAP2beta in the human osteosarcoma cell line U2OS, Mol. Cytogenet., 7, 10.1186/1755-8166-7-9 · DOI
  36. 10.1111/j.1432-1033.1996.0554z.x · doi:10.1111/j.1432-1033.1996.0554z.x
  37. Lavau, 1995, The acute promyelocytic leukaemia-associated PML gene is induced by interferon, Oncogene, 11, 871
  38. Stadler, 1995, Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element, Oncogene, 11, 2565
  39. 10.1093/nar/gkt555 · DOI · Paper page
  40. 10.1128/MCB.11.11.5586 · DOI · Paper page
  41. 10.1016/0092-8674(86)90463-0 · DOI · Paper page
  42. 10.1182/blood-2003-03-0708 · DOI
  43. 10.1242/dev.115584 · DOI · Paper page
  44. 10.1242/dev.108019 · DOI
  45. 10.1016/j.celrep.2014.09.044 · DOI · Paper page
  46. 10.1093/nar/gkh703 · DOI · Paper page
  47. Lin, 2014, Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery, Elife, 4, e04766, 10.7554/eLife.04766 · DOI · Paper page
  48. 10.1242/jcs.02817 · DOI
  49. 10.1083/jcb.200604009 · DOI · Paper page

Cited by

See all 279

Metadata

Authors
Pinder, J., Salsman, J., & Dellaire, G.
Venue
Nucleic Acids Research
Published
2015-10-01
Volume
43
Issue
19
Pages
9379-9392
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2154401446
Cited by
279
References
12
FWCI
9.13
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nuclear domain ‘knock-in’ screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing. https://app.cochat.ai/papers/10.1093/nar/gkv993
The paper
Pinder, J., Salsman, J., & Dellaire, G. (2015). Nuclear domain ‘knock-in’ screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing. Nucleic Acids Research. https://doi.org/10.1093/nar/gkv993

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.